Interact to see
Advertisement
Advertisement
ACSMX vs VEXPX
ACSMX vs VEXPX Comparison
Open Charts ACSMX vs VEXPX
Advisors Capital Small/Mid Cap
Price$11.23
Change+$0.06 (+0.54%)
VolumeN/A
Net Assets111.36M
ACSMX vs VEXPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
VEXPX has more cash in the bank: 20.6B vs. ACSMX (111M). VEXPX pays higher dividends than ACSMX: VEXPX (0.38) vs ACSMX (0.00). ACSMX was incepted earlier than VEXPX: ACSMX (5 years) vs VEXPX (58 years). ACSMX (1.87) is less costly to investors than VEXPX (0.44). VEXPX is a more actively managed with annual turnover of: 35.00 vs. ACSMX (8.26). ACSMX has a lower initial minimum investment than VEXPX: ACSMX (2500) vs VEXPX (3000). ACSMX annual gain was more profitable for investors over the last year : 2.46 vs. VEXPX (-3.30).
| ACSMX | VEXPX | ACSMX / VEXPX | |
| Total Expense Ratio | 1.87 | 0.44 | 425% |
| Annual Report Gross Expense Ratio | 1.87 | 0.44 | 425% |
| Fund Existence | 5 years | 58 years | - |
| Gain YTD | 4.174 | 4.672 | 89% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 111M | 20.6B | 1% |
| Annual Yield % from dividends | 0.00 | 0.38 | - |
| Returns for 1 year | 2.46 | -3.30 | -75% |
| Returns for 3 years | 45.28 | 25.83 | 175% |
| Returns for 5 years | N/A | 3.49 | - |
| Returns for 10 years | N/A | 34.37 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ETCHX | 37.65 | 0.05 | +0.13% |
| Eventide Healthcare & Life Sciences C | |||
| FTRIX | 30.16 | N/A | N/A |
| Fidelity Advisor Mega Cap Stock I | |||
| MSBQX | 11.49 | N/A | N/A |
| Morgan Stanley American Resilience R6 | |||
| IJEMX | 13.03 | -0.01 | -0.08% |
| VY® JPMorgan Emerging Markets Equity I | |||
| ACIOX | 11.70 | -0.05 | -0.43% |
| American Century International Opps I | |||